Clinical trials for Atypical teratoid rhabdoid tumor
15 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT06465199Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasMilton S. Hershey Medical Center · PI: Giselle Saulnier Sholler, MD
- RECRUITINGEarly Phase 1NCT07017816A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.Children's National Research Institute
- RECRUITINGPhase 2NCT06622941Study to ONO-4538 in Patients With Rhabdoid TumorOno Pharmaceutical Co. Ltd · PI: Project Leader
- RECRUITINGPhase 1NCT06193759Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)Children's National Research Institute · PI: Brian Rood, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05407441Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def TumorsSusan Chi, MD · PI: Susan Chi, MD
- RECRUITINGPhase 1NCT05835687Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS TumorsSt. Jude Children's Research Hospital · PI: Christopher DeRenzo, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05286801Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient TumorsNational Cancer Institute (NCI) · PI: Mary F Wedekind Malone
- ACTIVE NOT RECRUITINGPhase 2NCT06853080Feasibility of Using Bortezomib With or Without Chemotherapy in Patients With Atypical Teratoid/Rhabdoid TumorsTaipei Medical University
- ACTIVE NOT RECRUITINGPhase 2NCT04416568Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative CancersDana-Farber Cancer Institute · PI: Suzanne Forrest, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04483778B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsSeattle Children's Hospital · PI: Catherine Albert, MD
- RECRUITINGPhase 1NCT04185038Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsSeattle Children's Hospital · PI: Rebecca Ronsley, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03709680Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizer · PI: Pfizer CT.gov Call Center
- ACTIVE NOT RECRUITINGPhase 1NCT03500991HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsSeattle Children's Hospital · PI: Rebecca Ronsley, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02114229Phase 2 Study of Alisertib Therapy for Rhabdoid TumorsSt. Jude Children's Research Hospital · PI: Amar Gajjar, MD
- RECRUITINGPhase 2NCT01356290Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsMedical University of Vienna · PI: Andreas Peyrl, MD